Advertisement

A new medication, a new toxidrome - A case report of anticholinergic wipe toxicity due to improper medication use

Published:January 28, 2021DOI:https://doi.org/10.1016/j.ajem.2021.01.060

      Abstract

      We describe a case of a young female who presented to the emergency department with 4 days of progressive myopia, dry mouth, anhidrosis and urinary hesitancy due to overuse of a new topical anticholinergic wipes, glycopyrronium tosylate (GT). In the United States medication misuse accounts for nearly 10% of pediatric emergency visits with 65% of these visits considered to be preventable [1]. Being familiar with new medications and their side effect profiles can prevent unnecessary or harmful interventions.

      Keywords

      To read this article in full you will need to make a payment
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Emergency Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Zed P.J.
        • Black K.J.
        • Fitzpatrick E.A.
        • et al.
        Medication-related emergency department visits in pediatrics: a prospective observational study.
        Pediatrics. 2015; 135: 435-443https://doi.org/10.1542/peds.2014-1827
        • Glaser D.A.
        • Hebert A.A.
        • Nast A.
        • et al.
        Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials.
        J Am Acad Dermatol. 2019; 80 (e2): 128-138
      1. QBREXZA™ (glycopyrronium) cloth prescribing information. Dermira, 2018
        • Ludot M.
        • Mouchabac S.
        • Ferreri F.
        Inter-relationships between isotretinoin treatment and psychiatric disorders: depression, bipolar disorder, anxiety, psychosis and suicide risks.
        World J Psychiatry. 2015; 5: 222-227https://doi.org/10.5498/wjp.v5.i2.222
        • Cruz M.P.
        Guanfacine extended-release tablets (intuniv), a nonstimulant selective alpha(2A)-adrenergic receptor agonist for attention-deficit/hyperactivity disorder.
        P T. 2010; 35: 448-451
        • Broderick E.D.
        • Metheny H.
        • Crosby B.
        Anticholinergic toxicity. [Updated 2020 Jun 22].
        in: StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL)2020 Jan (Available from:)
        • Reilly Jr., J.F.
        • Weisse M.E.
        Topically induced diphenhydramine toxicity.
        J Emerg Med. 1990; 8: 59-61https://doi.org/10.1016/0736-4679(90)90389-d